Hemex News

October 11, 2025

Terumo Blood and Cell Technologies and Hemex Health join forces to improve outcomes for millions with sickle cell disease and other hemoglobin disorders

September 18, 2025

MedAccess working capital facility to help Hemex boost access to sickle cell diagnosis

June 20, 2024
New Research Confirms Hb Variant Test for Sickle Cell Gazelle Useful for Screening and Tracking Treatment Management‍ ‍

Feb 5, 2024
Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder

Oct 3, 2023
California State Treasurer and AllianceIndus Congratulate Hemex Health for India Partnerships That Led to a Breakthrough Affordable Test for Sickle Cell Disease

May 17, 2023
Eradication of Beta Thalassemia in India Will Require Low Cost Accurate Point-of-Care Testing with India Made Gazelle from HemexDx

Mar 27, 2023
Hemex Health Awarded $3M NIH Grant to Bring Gazelle Hb Cariant Test for Sickle Cell Disease to US Market

May 8, 2022
Hemex Health announces breakthrough measurement capability for Gazelle Diagnostic Device for clinicians monitoring SCD therapy

Nov 16, 2021
First Point-of-Care Test for Serious Hemoglobin Disorder Beta Thalassemia Provides New Weapon for the Front Lines of Healthcare Worldwide

Oct 13, 2021
Researchers in India's National Instituate of Research in Tribal Health Cofnirm Gazelle's Ability to Accurately Diagnost Sickle Cell Disease in Remote Regions

June 1, 2021
Newborn screening test for sickle cell disease now supported by Gazelle 8 minute point-of-care diagnostic

May 24, 2021
Hemex Health named TiE50 Award Winner at TiEcon

Apr 21, 2021
Hemex Health and Cureleads announce their partnership to commercialize AI based Gazelle® diagnostic device across Middle East, Turkey, and North Africa

Dec 5, 2020
Affordable Integrated Anemia and Sickle Cell Disease Test Demonstrates Accurate Results in Initial Study Data Presented at 2020 ASH Annual Meeting

June 17, 2020
Gazelle Diagnostic Platform Designed for Low Resource Settings Integrates Miniturized Tehcnologies with AI to Transform Disease Screening and Diagnosis

October 17, 2025
360Dx

Hemex Health Advances From Startup to Scale-up With New Partners, Funding [paywall]

360Dx profiled Hemex Health’s growth and partnerships in an in-depth feature by Madeleine Johnson. The article explores Hemex’s transition from startup to scale-up, supported by new collaborations with Terumo Blood and Cell Technologies, Syrma Johari Medtech, and MedAccess, and the company’s upcoming U.S. FDA submission.

March 29, 2023
WebIndia123

Hemex Health Co-founder & CEO Patti White, felicitated at ET Women Conclave 2025

March 29, 2023
Medical Life Sciences News

Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. market

August 22, 2022
Portland Business Journals

Global Impact Award: Hemex Health expands detection to underserved countries

July 31, 2022
IFC Health Newsletter | July 2022

Expert Voices: An Interview with Patti White of Hemex Health

March 21, 2022
CTIP Pediatric MedTech Accelerator

CTIP Announces 2022 Health Equity FlexGrant Winners

October 21, 2021
NIH: National Heart Blood and Lungs Institute

Future of medicine: Lab-on-a-chip devices starting to make an impact

September 28, 2021
NIH: Today's Faces of Sickle Cell Disease

Umut Gurkan, Ph.D, Sickle cell researcher, technology developer, and professor at Case Western Reserve University

June 15, 2021
Article from The Lok Doot, regional newspaper in India.

Accurate diagnosis by state-of-the-art machine

January 28, 2021
Novartis Monacle

Patti White, CEO, and Robin Roberts, Founder of the Novartis Biome, discuss a collaboration to bring diagnostics and therapeutics to Sub Sahara Africa

December 22, 2020
devex

Global health breakthroughs — other than for COVID-19 — in 2020

June 29, 2020
Novartis Live.

Biome is taking the fast lane

June 17, 2020
devex

'Optimized for the underserved': A new diagnostic test built for low-income settings

April 1, 2020
devex

Can a wave of innovation bring an end to sickle cell disease in sight?